Loading... (0%)
About liver disease
Genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs...
Learn more
NASH: Optimizing therapy for progressive disease April 2016
Watch

Press releases
  • GENFIT: Successful identification of RORγt inverse agonists as candidates for regulatory pre-IND studies
    09/23/2016
  • GENFIT: Significant Milestones Achieved under a New Qualification Program of Proprietary miRNAs and Algorithms for a Non-invasive NASH Diagnostic
    09/20/2016
  • GENFIT: First quarter 2016 financial information
    04/26/2016
Events